IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
申请人:F. HOFFMANN-LA ROCHE AG
公开号:EP1341766B1
公开(公告)日:2005-10-26
US6518293B2
申请人:——
公开号:US6518293B2
公开(公告)日:2003-02-11
[EN] IMIDAZOLONE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES<br/>[FR] DERIVES D'IMIDAZOLONE POUR LE TRAITEMENT DE MALADIES VIRALES
申请人:HOFFMANN LA ROCHE
公开号:WO2002042279A1
公开(公告)日:2002-05-30
The invention describes novel imidazolone derivatives as well as hydrolyzable esters or ethers of compounds of formula I and pharmaceutically acceptable salts thereof, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine (formula I) wherein R?1, R2, R3¿, A and X are as defined in the description. The compounds of formula I are the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents for HIV madiated process.
Anti-HIV imidazolone derivatives
申请人:——
公开号:US20020107272A1
公开(公告)日:2002-08-08
The invention is concerned with novel imidazolone derivatives, a process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is involved in viral replication. Consequently the compounds of this invention may be advantageously used as therapeutic agents against HIV infection.